Other
Progeria
0
Pipeline Programs↗
0
Active Trials↗
0
Companies Involved↗
Progeria is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
3
clinical trials
Unknown status2 · 67%
Completed1 · 33%
Clinical Trials
Trial Activity
A Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria
Completed·—·Phase 2·NCT00879034·5 enrolled
Study of Zoledronic Acid, Pravastatin, and Lonafarnib for Patients With Progeria
Unknown status·—·Phase 2·NCT00916747·85 enrolled
Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria
Unknown status·—·Phase 1/2·NCT02579044·80 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)